Zacks Research Issues Positive Forecast for A Earnings

Agilent Technologies, Inc. (NYSE:A) – Research analysts at Zacks Research raised their Q2 2026 EPS estimates for Agilent Technologies in a research note issued on Wednesday, December 11th. Zacks Research analyst R. Department now anticipates that the medical research company will post earnings per share of $1.47 for the quarter, up from their previous estimate of $1.46. The consensus estimate for Agilent Technologies’ current full-year earnings is $5.56 per share. Zacks Research also issued estimates for Agilent Technologies’ Q4 2026 earnings at $1.70 EPS and FY2027 earnings at $6.67 EPS.

A has been the topic of several other reports. Stifel Nicolaus reiterated a “buy” rating and set a $151.00 price objective on shares of Agilent Technologies in a research report on Monday, August 26th. Citigroup lifted their price objective on shares of Agilent Technologies from $150.00 to $165.00 and gave the stock a “buy” rating in a research report on Thursday, August 22nd. StockNews.com cut shares of Agilent Technologies from a “buy” rating to a “hold” rating in a research report on Tuesday, November 26th. JPMorgan Chase & Co. lowered their price objective on shares of Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating on the stock in a research report on Tuesday, November 26th. Finally, Barclays lowered their price objective on shares of Agilent Technologies from $145.00 to $135.00 and set an “underweight” rating on the stock in a research report on Wednesday, November 27th. One equities research analyst has rated the stock with a sell rating, seven have assigned a hold rating and seven have assigned a buy rating to the company’s stock. According to MarketBeat.com, Agilent Technologies currently has an average rating of “Hold” and a consensus target price of $143.62.

Agilent Technologies Price Performance

NYSE A opened at $137.68 on Monday. The stock has a market capitalization of $39.56 billion, a P/E ratio of 31.15, a P/E/G ratio of 4.48 and a beta of 1.07. Agilent Technologies has a 1 year low of $124.16 and a 1 year high of $155.35. The business’s fifty day moving average is $136.63 and its two-hundred day moving average is $136.42. The company has a debt-to-equity ratio of 0.57, a quick ratio of 1.58 and a current ratio of 2.09.

Agilent Technologies (NYSE:A) last announced its earnings results on Monday, November 25th. The medical research company reported $1.46 EPS for the quarter, topping the consensus estimate of $1.41 by $0.05. Agilent Technologies had a return on equity of 25.43% and a net margin of 19.80%. The firm had revenue of $1.70 billion for the quarter, compared to analysts’ expectations of $1.67 billion. During the same quarter in the previous year, the company earned $1.38 earnings per share. The firm’s quarterly revenue was up .8% compared to the same quarter last year.

Agilent Technologies Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 22nd. Stockholders of record on Tuesday, December 31st will be given a dividend of $0.248 per share. The ex-dividend date is Tuesday, December 31st. This represents a $0.99 dividend on an annualized basis and a dividend yield of 0.72%. This is a positive change from Agilent Technologies’s previous quarterly dividend of $0.24. Agilent Technologies’s dividend payout ratio is currently 22.40%.

Insider Activity

In other news, SVP Dominique Grau sold 9,990 shares of the company’s stock in a transaction dated Thursday, September 26th. The shares were sold at an average price of $145.00, for a total transaction of $1,448,550.00. Following the completion of the transaction, the senior vice president now owns 40,011 shares of the company’s stock, valued at approximately $5,801,595. This represents a 19.98 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. 0.33% of the stock is owned by company insiders.

Institutional Trading of Agilent Technologies

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Menard Financial Group LLC raised its holdings in shares of Agilent Technologies by 1.6% in the second quarter. Menard Financial Group LLC now owns 4,845 shares of the medical research company’s stock valued at $628,000 after buying an additional 77 shares during the last quarter. McAdam LLC raised its stake in shares of Agilent Technologies by 3.1% in the third quarter. McAdam LLC now owns 2,531 shares of the medical research company’s stock worth $376,000 after acquiring an additional 77 shares during the last quarter. Brown Brothers Harriman & Co. lifted its position in shares of Agilent Technologies by 13.5% during the third quarter. Brown Brothers Harriman & Co. now owns 646 shares of the medical research company’s stock worth $96,000 after purchasing an additional 77 shares in the last quarter. Global Retirement Partners LLC grew its stake in shares of Agilent Technologies by 3.2% during the third quarter. Global Retirement Partners LLC now owns 2,570 shares of the medical research company’s stock valued at $382,000 after purchasing an additional 79 shares during the last quarter. Finally, Rovin Capital UT ADV grew its stake in shares of Agilent Technologies by 1.6% during the third quarter. Rovin Capital UT ADV now owns 5,049 shares of the medical research company’s stock valued at $750,000 after purchasing an additional 81 shares during the last quarter. Institutional investors own 87.42% of the company’s stock.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.